The study will evaluate the BiWaze Clear System in patients with bronchiectasis
EAGAN, Minnesota—ABM Respiratory Care, a provider of respiratory therapy solutions, announced the initiation of a multi-center homecare study in collaboration with Delve Health, which specializes in decentralized clinical trial technology, to evaluate the impact of its BiWaze Clear System in patients living with bronchiectasis. The study will assess how the BiWaze Clear System affects respiratory health over a six-month period.
